Hosted on MSN25d
Clearwater Analytics to buy Enfusion for $11.25 a shareThe acquisition positions Clearwater to expand into the hedge fund industry. By adding dedicated engineering, product, and client operations teams, Clearwater aims to accelerate growth and drive ...
By combining both sets of solutions and engineering expertise, Clearwater aims to significantly enhance its right to win with asset managers across various segments, geographies, and sizes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results